These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 31410190)
1. Modulation of Respiration and Mitochondrial Dynamics by SMAC-Mimetics for Combination Therapy in Chemoresistant Cancer. Hagenbuchner J; Oberacher H; Arnhard K; Kiechl-Kohlendorfer U; Ausserlechner MJ Theranostics; 2019; 9(17):4909-4922. PubMed ID: 31410190 [TBL] [Abstract][Full Text] [Related]
2. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism. Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169 [TBL] [Abstract][Full Text] [Related]
3. Identification of Smac mimetics as novel substrates for p-glycoprotein. Hugle M; Czaplinski S; Habermann K; Vogler M; Fulda S Cancer Lett; 2019 Jan; 440-441():126-134. PubMed ID: 30312727 [TBL] [Abstract][Full Text] [Related]
4. Smac mimetics can provoke lytic cell death that is neither apoptotic nor necroptotic. Miles MA; Caruso S; Baxter AA; Poon IKH; Hawkins CJ Apoptosis; 2020 Aug; 25(7-8):500-518. PubMed ID: 32440848 [TBL] [Abstract][Full Text] [Related]
5. Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac. Huang Y; Rich RL; Myszka DG; Wu H J Biol Chem; 2003 Dec; 278(49):49517-22. PubMed ID: 14512414 [TBL] [Abstract][Full Text] [Related]
7. Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib. Lecis D; Drago C; Manzoni L; Seneci P; Scolastico C; Mastrangelo E; Bolognesi M; Anichini A; Kashkar H; Walczak H; Delia D Br J Cancer; 2010 Jun; 102(12):1707-16. PubMed ID: 20461078 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP. Sun H; Nikolovska-Coleska Z; Lu J; Meagher JL; Yang CY; Qiu S; Tomita Y; Ueda Y; Jiang S; Krajewski K; Roller PP; Stuckey JA; Wang S J Am Chem Soc; 2007 Dec; 129(49):15279-94. PubMed ID: 17999504 [TBL] [Abstract][Full Text] [Related]
9. Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic. Cossu F; Milani M; Vachette P; Malvezzi F; Grassi S; Lecis D; Delia D; Drago C; Seneci P; Bolognesi M; Mastrangelo E PLoS One; 2012; 7(11):e49527. PubMed ID: 23166698 [TBL] [Abstract][Full Text] [Related]
10. Structural basis for bivalent Smac-mimetics recognition in the IAP protein family. Cossu F; Milani M; Mastrangelo E; Vachette P; Servida F; Lecis D; Canevari G; Delia D; Drago C; Rizzo V; Manzoni L; Seneci P; Scolastico C; Bolognesi M J Mol Biol; 2009 Sep; 392(3):630-44. PubMed ID: 19393243 [TBL] [Abstract][Full Text] [Related]
11. A dimeric Smac/diablo peptide directly relieves caspase-3 inhibition by XIAP. Dynamic and cooperative regulation of XIAP by Smac/Diablo. Gao Z; Tian Y; Wang J; Yin Q; Wu H; Li YM; Jiang X J Biol Chem; 2007 Oct; 282(42):30718-27. PubMed ID: 17724022 [TBL] [Abstract][Full Text] [Related]
12. Differential role of RIP1 in Smac mimetic-mediated chemosensitization of neuroblastoma cells. Czaplinski S; Abhari BA; Torkov A; Seggewiß D; Hugle M; Fulda S Oncotarget; 2015 Dec; 6(39):41522-34. PubMed ID: 26575016 [TBL] [Abstract][Full Text] [Related]
13. The Smac mimetic RMT5265.2HCL induces apoptosis in EBV and HTLV-I associated lymphoma cells by inhibiting XIAP and promoting the mitochondrial release of cytochrome C and Smac. Ramachandiran S; Cain J; Liao A; He Y; Guo X; Boise LH; Fu H; Ratner L; Khoury HJ; Bernal-Mizrachi L Leuk Res; 2012 Jun; 36(6):784-90. PubMed ID: 22325366 [TBL] [Abstract][Full Text] [Related]
14. Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma. Wu MS; Wang GF; Zhao ZQ; Liang Y; Wang HB; Wu MY; Min P; Chen LZ; Feng QS; Bei JX; Zeng YX; Yang D Mol Cancer Ther; 2013 Sep; 12(9):1728-37. PubMed ID: 23699656 [TBL] [Abstract][Full Text] [Related]
15. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP. Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396 [TBL] [Abstract][Full Text] [Related]
16. Novel second mitochondria-derived activator of caspases (Smac) mimetic compounds sensitize human leukemic cell lines to conventional chemotherapeutic drug-induced and death receptor-mediated apoptosis. Servida F; Lecis D; Scavullo C; Drago C; Seneci P; Carlo-Stella C; Manzoni L; Polli E; Lambertenghi Deliliers G; Delia D; Onida F Invest New Drugs; 2011 Dec; 29(6):1264-75. PubMed ID: 20614162 [TBL] [Abstract][Full Text] [Related]
17. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles. Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976 [TBL] [Abstract][Full Text] [Related]
18. Bax/Bak-dependent, Drp1-independent Targeting of X-linked Inhibitor of Apoptosis Protein (XIAP) into Inner Mitochondrial Compartments Counteracts Smac/DIABLO-dependent Effector Caspase Activation. Hamacher-Brady A; Brady NR J Biol Chem; 2015 Sep; 290(36):22005-18. PubMed ID: 26134559 [TBL] [Abstract][Full Text] [Related]
19. SMAC mimetic (JP1201) sensitizes non-small cell lung cancers to multiple chemotherapy agents in an IAP-dependent but TNF-α-independent manner. Greer RM; Peyton M; Larsen JE; Girard L; Xie Y; Gazdar AF; Harran P; Wang L; Brekken RA; Wang X; Minna JD Cancer Res; 2011 Dec; 71(24):7640-8. PubMed ID: 22049529 [TBL] [Abstract][Full Text] [Related]
20. Survivin interacts with Smac/DIABLO in ovarian carcinoma cells but is redundant in Smac-mediated apoptosis. McNeish IA; Lopes R; Bell SJ; McKay TR; Fernandez M; Lockley M; Wheatley SP; Lemoine NR Exp Cell Res; 2005 Jan; 302(1):69-82. PubMed ID: 15541727 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]